Cite

    M Rudwaleit et al.. “Adalimumab effectively reduces the rate of anterior uveitis flares in patients with active ankylosing spondylitis: results of a prospective open-label study.” Annals of the rheumatic diseases, vol. 68, no. 5, 2009, pp. 696–701. http://access.bl.uk/ark:/81055/vdc_100137791829.0x00005e